Eledon Pharmaceuticals, Inc.

NASDAQ:ELDN

Biotechnology

Healthcare
$2.03 +2.84%

+$0.11 today

Market cap
$171.45M
Beta
0.97
P/E (TTM)
-5.5
EPS (TTM)
-$0.70
52W Low $1.35High $4.60

Volume 1.12M

Average 1.37M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$83.25M

FY 2025 · Annual

Net Income

-$45.62M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development23.74M27.08M30.31M51.96M66.27M
Selling, General & Admin13.13M12.7M12.69M18.61M16.98M
Operating Expenses36.87M88.43M43M70.58M83.25M
Depreciation & Amortization195K373K374K359K313K
EBITDA(36.67M)(39.41M)(116.16M)(35.39M)(45.27M)
EBITDA Margin—————
Operating Income(36.87M)(88.43M)(43M)(70.58M)(83.25M)
Operating Margin—————
Interest Income00000
Interest Expense00000
Other Income / Expenses7K462K(73.54M)34.82M37.67M
Income Before Tax(36.86M)(87.97M)(116.54M)(35.75M)(45.58M)
Pre-Tax Margin—————
Income Tax Expense(2.35M)00431K35K
Net Income(34.51M)(87.97M)(116.54M)(36.18M)(45.62M)
Net Margin—————
EPS (Basic)(2.33)(6.16)(4.73)(0.75)(0.56)
EPS (Diluted)(2.33)(6.16)(4.73)(0.75)(0.56)
Weighted Avg Shares14.82M14.29M24.62M48.54M81.84M
Weighted Avg Shares (Diluted)14.82M14.29M24.62M48.54M81.84M

ELDN Earnings Waterfall · TTM

NASDAQ:ELDN · Revenue to Net Income

Key Ratios

EPS$-0.87
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.1
P/S Ratio0.0

Analysis

$0 of revenue converted into -$78.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.87, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
SC 13G/ASC 13G/A filingOct 30, 2026
S-8S-8 filingSep 4, 2026
10-QQuarterly reportAug 13, 2026

How much revenue does ELDN generate?

Eledon Pharmaceuticals, Inc. (ELDN) reported $0.00 of revenue in fiscal 2025.

Is ELDN profitable?

Eledon Pharmaceuticals, Inc. (ELDN) reported -$45.62M of net income.